Smith & Nephew SNATS (SNN)
(Delayed Data from NYSE)
$25.56 USD
+0.28 (1.11%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $25.55 -0.01 (-0.04%) 6:04 PM ET
4-Sell of 5 4
A Value B Growth A Momentum A VGM
Smith & Nephew (SNN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$35.25 | $37.50 | $33.00 | 39.44% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Smith & Nephew comes to $35.25. The forecasts range from a low of $33.00 to a high of $37.50. The average price target represents an increase of 39.44% from the last closing price of $25.28.
Analyst Price Targets (2 )
Broker Rating
Smith & Nephew currently has an average brokerage recommendation (ABR) of 1.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 1.44 a month ago based on nine recommendations.
Of the nine recommendations deriving the current ABR, six are Strong Buy, representing 66.67% of all recommendations. A month ago, Strong Buy represented 77.78%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 7 | 7 | 9 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.67 | 1.67 | 1.44 | 1.44 | 1.36 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
11/1/2024 | Not Identified | Not Identified | Hold | Hold |
9/5/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/20/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/5/2024 | UBS | Graham Doyle | Hold | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.67 |
ABR (Last week) | 1.67 |
# of Recs in ABR | 9 |
Average Target Price | $35.25 |
LT Growth Rate | 11.30% |
Industry | Medical - Products |
Industry Rank by ABR | 82 of 252 |
Current Quarter EPS Est: | NA |
SNN FAQs
Smith & Nephew SNATS, Inc. (SNN) currently has an average brokerage recommendation (ABR) of 1.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 9 brokerage firms.
The average price target for Smith & Nephew SNATS, Inc. (SNN) is $35.25. The current on short-term price targets is based on 4 reports.
The forecasts for Smith & Nephew SNATS, Inc. (SNN) range from a low of $33 to a high of $37.5. The average price target represents a increase of $39.44 from the last closing price of $25.28.
The current UPSIDE for Smith & Nephew SNATS, Inc. (SNN) is 39.44%
Based on short-term price targets offered by two analysts, the average price target for Smith & Nephew comes to $35.25. The forecasts range from a low of $33.00 to a high of $37.50. The average price target represents an increase of 39.44% from the last closing price of $25.28.